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Why are horses vaccinated? 
The ability to mount a defense against disease 
comes from a healthy immune system. Immunologists 
recognize that there are two basic forms of immunity, 
innate and active. Innate or passive immunity involves 
defensive immune responses that are passively acquired 
to combat disease. Most animals are born with several 
innate immune mechanisms and require additional 
immunity from ingestion of immunoglobulins 
(antibodies) from their mother’s colostrum (first milk). 
Innate immunity is not specific for disease agents and 
therefore not very efficient. Yet passive immunity 
provides a critical step between birth and the gearing up 
of the active immune system. 
Active immunity is more specific and generated 
from the animal’s own immune system as the animal is 
exposed to pathogens (antigens). Because active 
immunity is developed in response or exposure to 
disease, the immunity is more specific, but requires more 
time to develop. 
Animals are constantly exposed to disease 
pathogens. Vaccines are used as a tool to minimize the 
effect infectious diseases have on the animals through 
selectively manipulating the immune system. Vaccines 
have the ability to stimulate a more specific active 
immune response. 
 
How do repeated doses or “boosters” affect 
immunity? 
Boosters are required for most types of vaccines 
during the initial time given to fully stimulate the active 
immune system. These repeated doses (boosters) create 
an immune response that is longer in duration with a 
quicker response. The ability for an immune system to 
remember foreign pathogens and respond accordingly is 
called the animistic response. 
Foals require a series of boosters after the initial 
vaccine is given. As a foal’s immune system matures, 
the first dose is often less effective when compared to 
subsequent boosters. It is critical to remember to 
administer the entire series of recommended shots in a 
given vaccine protocol. 
 
Why do vaccinated horses have vaccine 
breakthroughs? 
Vaccine breakthrough happens when animals get 
the disease even though they have been vaccinated. The 
primary culprit to this event is stress. Stress can affect 
the immune system in many different ways. In general, 
stress decreases the body’s ability to mount or maintain 
an effective immunity. The biochemistry behind stress’s 
negative effect on immunity is simply the over 
production of steroid (cortisol) in the body. This internal 
cortisol release may decrease the production and 
response of the immune system. 
In the equine industry stress is most commonly 
found with weaning, training, traveling, and during 
gestation. Other times of stress can include the ambient 
temperature the horse is in. When seasons are drastic, 
and horses are exposed to hot and cold extremes, a 
horse’s stress level may increase. 
The vaccine recommendations vary from horse 
to horse depending on its stage of life and stress levels 
For example, the recommendation for equine influenza 
may increase if the horse is competing, yet decrease as 
the same horse is being rested for a season.  
Another issue that can affect vaccine 
effectiveness is exposure. A vaccinated horse may come 
in contact with another horse that is shedding the 
disease. This increased exposure to the organism may be 
at levels which overwhelm the protective immunity of 
the vaccinated horse causing clinical signs. This can be a 
common cause of vaccine breakthrough. 
Is following the label instructions 
important?  
Each vaccine is packaged with label instructions. 
When administering any biological agent to a horse, one 
must first read the label and be familiar with stated 
precautions. Some vaccines contain warnings or 
precautions that should be followed to minimize the risk 
to horse and/or human. Vaccines should always be used 
prior to the expiration date and stored at the correct 
temperature indicated on the label. Vaccines are most 
effective when administered according to the label. If the 
route of administration is intramuscular, giving the 
injection just under the skin (subcutaneously) may not 
produce an equivalent immune response than the route 
indicated on the label. 
 
Which diseases should I vaccinate my 
horse against? 
A number of diseases can be prevented or the 
affect lessened through the use of vaccinations. While 
the purpose of this paper is to discuss vaccinations; 
management and biosecurity also play a critical role in 
the prevention of disease. Any good vaccination protocol 
should include thought and planning in management and 
biosecurity. Consideration should be given to your 
horse’s exposure to common diseases. Horses that travel 
or are around other horses will have an increased 
exposure risk. It is critical to consult a veterinarian when 
developing a vaccination program as they can provide 
critical insight into the similarities and differences that 
one farm may have versus another. 
Not all equine diseases are found throughout the 
United States or even throughout Utah. Therefore it is 
critical to discuss the common diseases seen in your area 
with a veterinarian. This conversation is essentially a 
risk assessment for equine diseases in the area. Those 
diseases recognized as common should be considered 
first when designing a vaccine strategy. 
 
Vaccine Recommendationsi 
The American Association of Equine 
Practitioners (AAEP), made up of equine veterinarians 
throughout the world, has developed vaccination 
recommendations for many classes and stages of a 
horse’s life and lifestyle. These recommendations 
identify the minimal core vaccine...  Core vaccines are 
defined as vaccinations 
 “that protect from diseases that are endemic to 
a region, those with potential public health 
significance, required by law, virulent/highly 
infectious, and/or those posing a risk of severe 
disease. Core vaccines have clearly 
demonstrated efficacy and safety, and thus 
exhibit a high enough level of patient benefit and 
low enough level of risk to justify their use in the 
majority of patients.”ii   
The attached guidelines list the core vaccines 
along with a variety of other potential vaccines. Again, a 
vaccination program must be fitted to each individual 
stable’s situation (training facility, competing, boarding 
facility, etc.) and potential exposure to disease. 
Furthermore, horses in various life stages may require 
different vaccine considerations. The table is broken 
down into different life stages. Your veterinarian can 
assist in this evaluation. (Click on title to go directly to 
table.) 
 Vaccinations for Foals 
 Vaccinations for Adult Horses 
 
What are the core vaccines recommended 
for Utah? 
Minimally, Utah horse owners should consider 
including tetanus, Eastern and Western equine 
encephalitis (EEE/WEE), and West Nile Virus (WNV) 
each year. The core vaccines could expand should the 
horse’s travel expose it to other disease endemic areas, 
such as rabies. While Utah does not have reported cases 
of equine rabies, many neighboring states do (Colorado) 
and it is more common as you travel east. 
 
Core vaccines for Utah: 
• Tetanus 
• Eastern and Western equine encephalitis 
(EEE/WEE) 
• West Nile Virus (WNV) 
• Rabies (for the public health aspect) 
 
Which risk-based vaccines are commonly 
used in Utah? 
Depending on stage of life, event activity and 
travel, the following risk-based vaccination regiment 
should be considered. Veterinarians also may 
recommend additional vaccines during gestation to help 
protect the fetus, along with increasing the quality of 
colostrum (mother’s first milk).  
 
Risk-based vaccines to consider are: 
• Influenza  
• Equine herpes virus (EHV) 
• Strangles (if stable, show, or event requires; or if 
environmental risk is high) 
 
Injection Sites 
Vaccines have a specific route of administration 
indicated on their label. Common routes used are 
intramuscular (in the muscle), intranasal (in the nostril), 
and subcutaneous (SQ). The most common route is IM. 
There are several sites with quality muscle mass that are 
safe for vaccinations.  Most vaccine type injections are 
given with a 20 gauge 1 to 1 ½ inch sterile needle and 
sterile syringe. Locations for injections (Figure 1) 
include the neck, pectorals, shoulder, lower hip, and 
thigh regions.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Many people only give IM injections in the neck 
region but being aware of other sites is important. Some 
horses react to injections in the neck causing the neck to 
be sore. Some of these horses will not be able to put 
their heads down to eat or drink. Being able to give an 
injection in another site can make the horse more 
comfortable.  
Many veterinarians will teach horse owners how 
to give injections. It is important to consult with your 
veterinarian before giving an injection. 
 
Steps for giving an injection 
1. Use sterile needles and syringes 
2. Clean off site. This area does not need to be 
sterile but dirt should be brushed off. 
3. Stand in a safe area so horse can’t kick or bite 
you. Having a holder is important. 
4. Remove the needle from the syringe. This helps 
the needle remain in the muscle if the horse 
moves away once the needle is inserted. 
5. Bounce your hand or finger several times in the 
site. 
6. Insert the needle perpendicular to the skin and 
full length of needle. 
7. Attach the syringe and pull back on the plunger 
(aspirate). If blood is seen in the syringe upon 
aspirating, the needle should be redirected as IM 
substances are not meant to go into a blood 
vessel. To redirect, the needle can be backed out 
about one-half of its length and then directed 
back in on a different angle. Aspirate again. 
8. Deposit the substance and remove the needle, 
dispose of the needle and syringe. 
 
 
Summary 
Vaccinations are an important part of horse 
management. Your horse can remain healthier when 
protected from diseases. Disease prevention is often less 
expensive than treatment or loss associated with disease.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The American Association of Equine 
Practitioners (AAEP) has specific core and risk-based 
vaccine recommendations for your horse. Using these 
recommendations along with consultation with your 
local veterinarian can form the basis for a preventative 
health program specific for your area, needs, and horse. 
 
 
                                                            
i Adapted From American Association of Equine Practitioners 
(AAEP) 
ii AVMA Policy Statement: Vaccination Principles (Approved 
by the AVMA Executive Board April 2001; revised April 2007). 
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VACCINATIONS FOR FOALS 
 
**ALL VACCINATION PROGRAMS SHOULD BE DEVELOPED IN CONSULTATION WITH A LICENSED 
VETERINARIAN** 
 
The two categories below reflect differences in the foal’s susceptibility to disease and ability to mount an appropriate immune 
response to vaccination based on the presence (or absence) of maternal antibodies derived from colostrums. The phenomenon of 
maternal antibody interference is discussed in the text portion of these guidelines. 
 
CORE VACCINATIONS protect against diseases that are endemic to a region, those with potential public health significance, 
required by law, virulent/highly infectious, and/or those posing a risk of severe disease.  Core vaccines have clearly 
demonstrated efficacy and safety, and thus exhibit a high enough level of patient benefit and low enough level of risk to justify 
their use in all equids. 
 
 Foals and Weanlings 
(<12 months of age) 
 
Of mares vaccinated in the prepartum 
period against the disease indicated 
Foals and Weanlings 
(<12 months of age) 
 
Of unvaccinated mare 
 
DISEASE   COMMENTS 
Tetanus 3-dose series: 
   1st dose at 4-6 months of age 
   2nd dose 4-6 weeks after the 1st dose 
   3rd dose at 10-12 months of age 
3-dose series: 
   1st dose at 1-4 months of age 
   2nd dose at 4 weeks after the 1st dose 
   3rd dose 4 weeks after 2nd dose 
 
Eastern/Western 
Equine 
Encephalomyelitis 
(EEE/WEE) 
3-dose series: 
   1st dose at 4-6 months of age* 
   2nd dose at 4-6 weeks after 1st dose 
   3rd dose at 10-12 months of age, 
   prior to the onset of the next vector 
   season. 
 
*Foals in the Southeastern USA: 
The primary vaccination series should 
be initiated with an additional dose at 
3 months of age due to early seasonal 
vector presence. 
3-dose series: 
   1st dose at 3-4 months of age* 
   2nd dose 4 weeks after 1st dose 
   3rd dose at 10-12 months of age, 
   prior to the onset of the next vector 
   season. 
 
*Foals in the Southeastern USA:  
The primary vaccination series should 
be initiated at 3 months of age due to 
early seasonal vector presence. 
Note:  Primary vaccination series 
scheduling may be amended with 
vaccinations administered earlier 
to younger foals that are at 
increased disease risk due to the 
presence of vectors. 
 
A foal born during the vector 
season may warrant beginning 
vaccination at an earlier age than a 
foal born prior to the vector 
season. 
Rabies 3-dose series: 
   1st dose at 6 months of age 
   2nd dose 4-6 weeks after 1st dose 
   3rd dose at 10-12 months of age 
3-dose series: 
   1st dose at 3-4 months of age 
   2nd dose 4 weeks after 1st dose 
   3rd dose at 10-12 months of age 
 
West Nile Virus 
(WNV) 
Inactivated vaccine* 
   3-dose series: 
   1st dose at 4-6 months of age 
   2nd dose 4-6 weeks after 1st dose 
   3rd dose at 10-12 months of age,  
   prior to the onset of the next vector  
   season. 
Recombinant canary pox vaccine 
   3-dose series: 
   1st dose at 5-6 months of age 
   2nd dose 4 weeks after 1st dose 
   3rd dose at 10-12 months of age,  
   prior to the onset of the next vector  
   season. 
 
Flavivirus chimera vaccine 
   2-dose series: 
   1st dose at 5-6 months of age 
   2nd dose at 10-12 months of age,  
Inactivated vaccine* 
   3-dose series: 
   1st dose at 3-4 months of age 
   2nd dose at 4 weeks after 1st dose 
   3rd dose at 10-12 months of age,  
   prior to the onset of the next vector  
   season. 
Recombinant canary pox vaccine 
   3-dose series: 
   1st dose at 5-6 months of age 
   2nd dose at 4 weeks after 1st dose 
   3rd dose at 10-12 months of age,   
   prior to the onset of the next vector  
   season. 
 
Flavivirus chimera vaccine 
   2-dose series: 
   1st dose at 5-6 months of age 
   2nd dose at 10-12 months of age  
Note:  Primary vaccination series 
scheduling may be amended with 
vaccinations administered to 
younger foals that are at increased 
risk of exposure due to the 
presence of vectors. 
 
A foal born during the vector 
season may warrant initiation of 
the primary vaccination series at 
an earlier age than a foal born prior 
to the vector season 
 
 
 
There is no data for the use of the 
recombinant or chimera product in 
foals <5 months of age.  If either 
product is administered to foals at 
   prior to the onset of the next vector  
   season. 
 
*Foals in the Southeastern USA: 
Due to early seasonal vector presence, 
the primary vaccination series should 
be initiated earlier with the addition of 
a dose at 3 months of age. 
   prior to the onset of the next vector  
   season. 
 
*Foals in the Southeastern USA: 
Due to early seasonal vector presence, 
the primary vaccination series should 
be initiated at 3 months of age. 
<5 months of age, the 
recommended primary schedule 
should still be completed. 
 
 
RISK-BASED VACCINATIONS are those having applications which may vary between individuals, populations, and 
geographic regions.  Risk assessment should be performed by, or in consultation with, a licensed veterinarian to identify which 
vaccines are appropriate for a given horse or population of horses. The listing of a vaccine here is not a recommendation for 
its inclusion into a vaccination program.  Vaccine scheduling is provided for use after it has been determined which, if any, 
risk-based vaccines are indicated.  Note:  vaccines are listed in this table in alphabetical order not in order of priority for use. 
 
DISEASE Foals and Weanlings 
(<12 months of age) 
 
Of mares vaccinated in the 
prepartum period against the disease 
indicated 
Foals and Weanlings 
(<12 months of age) 
 
Of unvaccinated mares 
COMMENTS 
Anthrax Not applicable.  As it is not 
recommended to vaccinate mares 
during pregnancy there will be no 
foals of mares vaccinated prepartum 
No age specific guidelines are 
available for this vaccine. 
 
Manufacturer’s recommendation is for 
primary series of 2 doses administered 
subcutaneously at a 2-3 week interval. 
Antimicrobial drugs must not be 
given concurrently with this 
vaccine. 
 
Caution should be used during 
storage, handling and 
administration of this live 
bacterial product.  Consult a 
physician immediately should 
accidental human exposure (via 
mucus membranes, conjunctiva or 
broken skin) occur. 
Botulism 3-dose series: 
   1st dose 2-3 months of age 
   2nd dose 4 weeks after 1st dose 
   3rd dose 4 weeks after 2nd dose 
3-dose series: 
   1st dose 1-3 months of age 
   2nd dose 4 weeks after 1st dose 
   3rd dose 4 weeks after 2nd dose 
Maternal antibody does not 
interfere with vaccination; foals at 
high risk may be vaccinated as 
early as 2 weeks of age. 
Equine 
Herpesvirus 
(EHV) 
Inactivated or modified live vaccine 
3-dose series: 
   1st dose 4-6 months of age 
   2nd dose 4-6 weeks after 1st dose 
   3rd dose at 10-12 months of age 
 
Revaccinate at 6-month intervals 
Inactivated or modified live vaccine 
3-dose series: 
   1st dose of 4-6 months of age 
   2nd dose 4-6 weeks after 1st dose 
   3rd dose at 10-12 months of age 
 
Revaccinate at 6-month intervals. 
 
Equine Viral 
Arteritis (EVA) 
Colt (male) foals:  Single dose at 6-
12 months of age (see comments) 
Colt (male) foals:  Single dose at 6-12 
months of age (see comments) 
Prior to initial vaccination, colt 
(male) foals should undergo 
serologic testing  and be 
confirmed negative for antibodies 
to EAV.   Testing should be 
performed shortly prior to, or 
preferably at, the time of 
vaccination. 
 
As foals can carry colostral 
derived antibodies to EAV for up 
to 6 months, testing and 
vaccination should not be 
performed prior to 6 months of 
age. 
    
Equine Influenza Inactivated vaccine 
3-dose series: 
   1st dose at 6 months of age 
   2nd dose 3-4 weeks after 1st dose 
   3rd dose at 10-12 months of age 
 
Modified live vaccine 
2-dose series administered 
intranasally: 
   1st dose at 6-7 months of age 
   2nd dose at 11-12 months of age 
 
Revaccinate at 6-month intervals 
Inactivated vaccine 
3-dose series: 
   1st dose at 6 months of age 
   2nd dose at 3-4 weeks after 1st dose 
   3rd dose at 10-12 months of age 
 
Modified live vaccine 
2-dose series administered intranasally: 
   1st dose at 6-7 months of age 
   2nd dose at 11-12 months of age 
 
 Revaccinate at 6-month intervals 
An increased risk of disease may 
warrant vaccination of younger 
foals.  Because some maternal, 
anti-influenza antibody is likely to 
be present, a complete series of 
primary vaccinations should be 
given after 6 months of age. 
Potomac Horse 
Fever (PHF) 
2-dose series: 
   1st dose at 5 months of age 
   2nd dose 3-4 weeks after 1st dose 
2-dose series: 
   1st dose at 5 months of age 
   2nd dose 3-4 weeks after 1st dose 
If risk warrants, vaccine may be 
administered to younger foals.  
Subsequent doses are to be 
administered at 4-week intervals 
until 6 months of age. 
Rotavirus Not recommended in foals Not recommended in foals  
Strangles 
Streptococcus equi 
Killed vaccine 
3-dose series: 
   1st dose at 4-6 months of age 
   2nd dose 4-6 weeks after 1st dose 
   3rd dose 4-6 weeks after 2nd dose 
 
Modified live vaccine 
3-dose series administered 
intranasally: 
   1st dose at 6-9 months of age 
   2nd dose 3-4 weeks after 1st dose 
   3rd dose at 11-12 months of age 
Killed vaccine 
3-dose series: 
   1st dose at 4-6 months of age 
   2nd dose 4-6 weeks after 1st dose 
   3rd dose 4-6 weeks after 2nd dose 
 
Modified live vaccine 
3-dose series administered intranasally: 
   1st dose at 6-9 months of age 
   2nd dose 3-4 weeks after 1st dose 
   3rd dose at 11-12 months of age 
Vaccination is not recommended 
as a strategy in outbreak 
mitigation. 
 
If risk warrants, the modified live 
vaccine (MLV) may be safely 
administered to foals as young as 
6 weeks of age.  However, vaccine 
efficacy in this age group has not 
been adequately studied.  If MLV 
is administered to younger foals, a 
3rd dose of vaccine should then be 
administered 2-4 weeks prior to 
weaning. 
 
Vaccinations for Foals developed by the American Association of Equine Practitioners Infectious Disease Committee, 2008. 
 
                                                                                       Click here to return to page 2. 
  
VACCINATIONS FOR ADULT HORSES 
 
**ALL VACCINATION PROGRAMS SHOULD BE DEVELOPED IN CONSULTATION  
WITH A LICENSED VETERINARIAN** 
 
CORE VACCINATIONS protect against diseases that are endemic to a region, are virulent/highly contagious, pose a risk of 
severe disease, those having potential public health significance, and/or are required by law.  Core vaccines have clearly 
demonstrable efficacy and safety, with a high enough level of patient benefit and low enough level of risk to justify their use in 
all equids. 
 
 Broodmares Other Adult Horses 
(>1 year of age) 
 
Previously vaccinated 
against the disease 
indicated 
Other Adult Horses 
(>1 year of age) 
Unvaccinated 
or 
Lacking vaccination history 
 
DISEASE    COMMENTS 
Tetanus Previously vaccinated 
   Annual, 4-6 weeks pre-partum 
 
Previously unvaccinated or 
having unknown vaccination 
history: 
   2-dose series 
     2nd dose 4-6 weeks after 1st  
     dose 
     Revaccinate 4-6 weeks pre- 
     partum 
 
Annual 
 
2-dose series 
   2nd dose 4-6 weeks after 1st dose. 
   Annual revaccination 
 
Booster at time of 
penetrating injury or prior to 
surgery if last dose was 
administered over 6 months 
previously. 
Eastern/Western 
Equine 
Encephalomyelitis 
(EEE/WEE) 
Previously vaccinated: 
   Annual, 4-6 weeks pre-partum 
 
Previously unvaccinated or 
having unknown vaccination 
history: 
   2-dose series 
     2nd dose 4 weeks after 1st dose 
     Revaccinate 4-6 weeks pre- 
     partum 
 
Annual – spring, prior to 
onset of vector season 
 
2-dose series 
   2nd dose 4-6 weeks after 1st dose 
   Revaccinate prior to the onset of  
   the next vector season 
 
Consider 6-month 
revaccination interval for: 
 
1.  Horses residing in 
endemic areas 
2. Immunocompressed 
horses 
West Nile Virus 
(WNV) 
Previously vaccinated:  Annual, 
4-6 weeks pre-partum 
 
Unvaccinated or lacking 
vaccination history: 
It is preferable to vaccinate naïve 
mares when open. 
 
In areas of high risk, initiate 
primary series as described for 
unvaccinated adult horses. 
 
Annual – spring, prior to 
onset of vector season 
Inactivated vaccine: 2-dose series 
   2nd dose 4-6 weeks after 1st dose 
   Revaccinate prior to the onset of  
   the next vector season 
Recombinant canary pox vaccine: 
   2-dose series 
     2nd dose 4-6 weeks after 1st  
     dose 
     Revaccinate prior to the onset  
     of the next vector season 
Flavivirus chimera vaccine: 
   Single dose 
   Revaccinate prior to onset of the  
   next vector season 
When using the inactivated 
or the recombinant product, 
consider 6-month 
revaccination interval for: 
1. Horses residing in 
endemic areas 
2. Juvenile (<5 yrs of 
age) 
3. Geriatric horses (>15 
yrs of age) 
4. Immunocompressed 
horses 
Rabies Annual, 4-6 weeks pre-partum 
OR 
Prior to breeding* 
Annual Single dose 
Annual revaccination 
*Due to the relatively long 
duration of immunity, this 
vaccine may be given post-
foaling but prior to breeding 
and thus reduce the number 
of vaccines given to a mare 
pre-partum 
 
  
RISK-BASED VACCINES are selected for use based on risk assessment** performed by, or in consultation with, a licensed 
veterinarian.  Use of these vaccines may vary between individuals, populations, and/or geographic regions. 
Note:  Vaccines are listed in this table in alphabetical order, not in order of priority for use. 
 
**Refer to “Principles of Vaccination” in main document for criteria used in performing risk assessment. 
 
 Broodmares Other Adult Horses 
(>1 year of age) 
 
Previously vaccinated 
against the disease 
indicated 
Other Adult Horses 
(>1 year of age) 
 
Unvaccinated  
or 
Lacking vaccination history 
 
DISEASE    COMMENTS 
Anthrax Not recommended during 
gestation 
Annual 2-dose series 
   2nd dose 3-4 weeks after 1st dose 
   Annual revaccination 
Do not administer 
concurrently with antibiotics. 
 
Use caution during storage, 
handling and administration.  
Consult a physician 
immediately if human 
exposure to vaccine occurs 
by accidental injection, 
ingestion, or otherwise 
through the conjunctiva or 
broken skin. 
Botulism Previously vaccinated: 
   Annual, 4-6 weeks pre-partum 
 
Previously unvaccinated or 
having unknown vaccination 
history: 
   3-dose series 
     1st dose at 8 months gestation 
     2nd dose 4 weeks after 1st dose 
     3rd dose 4 weeks after 2nd dose 
 
Annual 
 
3-dose series 
    2nd dose 4 weeks after 1st dose 
    3rd dose 4 weeks after 2nd dose 
 
Annual revaccination 
 
Equine 
Herpesvirus 
(EHV) 
3-dose series with product labeled 
for protection against EHV 
abortion. 
 
Give at 5, 7 and 9 months of 
gestation. 
Annual (see comments) 3-dose series 
    2nd dose 4-6 weeks after 1st  
    dose 
    3rd dose at 4-6 weeks after 2nd  
    dose 
Consider 6-month 
revaccination interval for: 
1. Horses less than 5 
years of age. 
2. Horses on breeding 
farms or in contact 
with pregnant mares. 
3. Performance or show 
horses at high risk. 
Equine Viral 
Arteritis (EVA) 
Not recommended unless high 
risk. 
Annual 
 
Stallions, teasers: 
Vaccinate 2-4 weeks 
before breeding season. 
 
Mares:  Vaccinate when 
open. 
Single dose (see comments) Prior to initial vaccination, 
intact males and any horses 
potentially intended for 
export should undergo 
serologic testing and be 
confirmed negative for 
antibodies to EAV.  Testing 
should be performed shortly 
prior to, or preferably at, the 
time of vaccination. 
 
  
Influenza Previously vaccinated: 
  Inactivated vaccine:  Semi- 
  annual with one dose  
  administered 4-6 weeks pre- 
  partum 
  Canary pox vector vaccine: 
  Semi-annual with one dose  
  administered 4-6 weeks pre- 
  partum 
 
Previously unvaccinated or 
having unknown vaccination 
history: 
  Inactivated vaccine:  3-dose  
  series 
     2nd dose 4-6 weeks after 1st  
     dose 
     3rd dose 4-6 weeks pre-partum 
  Canary pox vector vaccine: 
     2-dose series 
        2nd dose 4-6 weeks after 1st  
        dose but no later than 4  
        weeks pre-partum 
Horses with ongoing risk 
of exposure: semi-annual 
 
Horses at low risk of 
exposure: 
Annual 
Modified live vaccine: 
Single dose administered 
intransally. 
Revaccinate semi-annually to 
annually. 
 
Inactivated vaccine: 3-dose series 
   2nd dose 4-6 weeks after 1st dose 
   3rd dose 3-6 months after 2nd  
   dose 
Revaccinate semi-annual to 
annually. 
 
Canary pox vector vaccine: 2-
dose series 
   2nd dose 4-6 weeks after 1st dose 
   Revaccinate semi-annually 
 
Potomac Horse 
Fever (PHF) 
Previously vaccinated:  Semi-
annual, with one dose given 4-6 
weeks prepartum. 
 
Previously unvaccinated or 
having unknown vaccination 
history: 
2-dose series 
   1st dose 7-9 weeks prepartum 
   2nd dose 4-6 weeks prepartum 
Semi-annual to annual 2-dose series 
   2nd dose 3-4 weeks after 1st dose 
   Semi-annual or annual booster 
A revaccination interval of 
3-4 months may be 
considered in endemic areas 
when disease risk is high 
Rotavirus 3-dose series 
   1st dose at 8 months gestation 
   2nd and 3rd dose at 4-week  
   intervals thereafter 
Not applicable Not applicable  
Strangles 
Streptococcus equi 
Previously vaccinated: 
  Killed vaccine containing M- 
  protein):  Semi-annual with one  
  dose given 4-6 weeks pre- 
  partum 
 
Previously unvaccinated or 
having unknown vaccination 
history: 
  Killed vaccine containing M- 
  protein): 3-dose series 
     2nd dose 2-4 weeks after 1st  
     dose 
     3rd dose 4-6 weeks prepartum 
Semi-annual to annual Killed vaccine containing M-
protein: 
2-3 dose series 
   2nd dose 2-4 weeks after 1st dose 
   3rd dose (where recommended  
   by manufacturer) 2-4 weeks  
   after 2nd dose 
   Revaccinate semi-annually 
 
Modified live vaccine:  2-dose 
series administered intranasally 
   2nd dose 3 weeks after 1st dose 
   Revaccinate semi-annually to  
   annually 
Vaccination is not 
recommended as a strategy 
in outbreak mitigation 
 
Vaccinations for Adult Horses developed by the American Association of Equine Practitioners Infectious Disease Committee, 2008. 
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